Tuberculosis Therapy
Study results from Duke University, Division of Infectious Diseases broaden understanding of tuberculosis therapy
Published in TB and Outbreaks Week, September 30th, 2008
Scientists discuss in 'The value of end-of-treatment chest radiograph in predicting pulmonary tuberculosis relapse' new findings in tuberculosis. According to a study from the United States, "Patients with cavitary pulmonary tuberculosis (TB) on baseline chest radiograph (CXR) who remain culture-positive after 8 weeks of treatment are at high risk of relapse. The role of end-of-treatment (EOT) CXR in predicting relapse is unclear."
"To determine whether EOT CXR independently predicts TB relapse. We conducted a secondary analysis of a randomized trial of intermittent treatment using rifapentine in the continuation phase of TB treatment among 1004 human immunodeficiency...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
More Articles from TB and Outbreaks Week
- Johns Hopkins University Bloomberg School of Public Health
New gene variant identified for nondiabetic end stage renal disease in African-Americans - Aspergillosis
Investigators at Fudan University target aspergillosis - Aspergillosis
Research from University of Texas broadens understanding of aspergillosis - Bird Flu
Reports from University of California advance knowledge in bird flu - Clinical Infectious Diseases
Studies from A.L. Agwu et al have provided new data on clinical infectious diseases - Clinical Trial Research
New clinical trial research research reported from S. Sundar and co-authors - More from this issue of TB and Outbreaks Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
